Document GKpjjxbBpee5ky6Vg6VE79pXN

Message From: Sent: To: Subject: [ "Ex.__ i 10/23/2017 6:33:57 pM Jones, Enesta [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=65b8e6c6e5ca4a7a9ae85d98a4c8eedb-EJones02]; Bowman, Liz [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=c3d4d94d3e4b4blf80904056703ebc80-Bowman, Eli]; Press [/o=ExchangeLabs/ou=Exchange Administrative Group (FYDIBOHF23SPDLT)/cn=Recipients/cn=b293283291dc44e0b5dlc36be9281d8a-Press] [SPAM] TERA documents to spark Dr. Dourson's memory on this paper. Fwd: Question regarding a paper by USEPA nominee Dr. Michael Dourson in the Regulatory Toxicology and Pharmacology archives. Reporter on deadline. Hello Again, Enesta, Ms. Bowman & Colleagues: As to the paper referenced below, it appears it was written on behalf of the City of Kearny, N.J. and sponsored by Chemical Land Holdings (descendant of Diamond Shamrock via Maxus Energy Corp.), the Kearny chrome manufacturer. I say that based on the Toxicology Excellence for Risk Assessment (TERA) material copied below. I seek Dr. Dourson's comment as to why TERA did work for the City of Kearny, paid for a company that had scattered toxic chromite slag all over Kearny. Seems a bit counter-intuitive. Please provide comment on this. Thanks, Daniel Forbes Cascadia Times Here's the links from TERA documents [note that the first cites the paper I'm inquiring about]: http://www.tera.org/about/1997%20annual%20report.pdf TERA's annual report for 1997. TERA published research on the risk assessment of chromium contaminated soils [Felter, S.P. and M.L. Dourson. 1997. Hexavalent chromium contaminated soils: Options for risk assessment and risk management. Reg. Tox. Pharmacol., 25(l):43-59], This work was done for the City of Kearny, New Jersey. xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx http://www.tera.org/Peer/HexavalentChromium1998MeetingReport.pdf ITER Peer Review on Hexavalent Chromium Meeting Summary April 16, 1998 Conference Call Sierra Club v. EPA 18cv3472 NDCA Tier 13 ED 002061 00024005-00001 Michael Dourson - Dr. Dourson is the Director of TERA. TERA has performed work for the City of Kearny, New Jersey which was paid for by Chemical Land Holdings, one of the chromium sponsors, on dermal issues related to exposure to chromium. This work does not create a conflict with the inhalation RfC for hexavalent chromium and therefore, Dr. Dourson may participate fully in the chromium discussions. xxxxxxxxxxxxxxxxxxxxxx --TSSForeuo:nbmjtOjoe::nrc!Mi_teg:o_sinQn_.ae,_uln2_eeM3_ss_tetiOo_asnc_s<ta_jr2g_oe0e_ng1--_ea7_rsd.E9einx:n.2ge64s_at_ap_@a_p_ee_pr_ab_.gy_o_Uv_S>_E;_bP_o_Aw] nmoamni.nlieze<Dbor.wMmicahna.leizl@Deoupras.ognovin>;thpereRsseg<uplraetsosry@Teopxaic.goolovg>y and Pharmacology archives. Reporter on deadline. Good Day, Enesta, Ms. Bowman & Colleagues: Daniel Forbes here, a reporter in Portland, Oregon. As you know, Dr. Michael L. Dourson has been in the news of late as a Trump Administration nominee for a senior regulatory post at USEPA. I write inquiring about a particular paper he authored on hex-chrome back in the 1990s, asking about its sponsorship. Along with, according to his CV, being on the editorial board of Regulatory Toxicology and Pharmacology since 1995, Dr. Dourson is also a Regulatory Toxicology and Pharmacology author. I refer specifically to Regulatory Toxicology and Pharmacology 25 43 - 59 (1997). Article No. RT 961073. (See Here.) The paper is entitled, "Hexavalent Chromium-Contaminated Soils: Options for Risk Assessment and Risk Management"; it was authored by Susan P. Felter and Dr. Dourson. Both were employed by Toxicology Excellence for Risk Assessment (TERA) at the time, Dr. Dourson's risk assessment consultancy. As mentioned, Dr. Dourson was also also on Reg Tox Pharm's editorial board. My question, please: I have the full text of the article. Nowhere in the text do I see any mention of sponsorship, if any. This was confirmed to me by Dr. Felter when I interviewed her this morning. It's my understanding that TERA did not typically undertake work sans funding. So, here's the question that prompts this query: who provided funding for the writing of this paper? It's worth noting that a TERA Hexavalent Chromium ITER Peer Review in April 1998 was funded by the chromium manufacturer, Elementis Chromium and the legacy chromium manufacturers, Chemical Land Holdings and PPG Industries, Inc., the latter two with responsibility Sierra Club v. EPA 18cv3472 NDCA Tier 13 ED 002061 00024005-00002 for remediation of chromite ore processing residue distributed as building fill throughout Hudson County, N.J. The Senate Environment and Public Works Committee will vote on Dr. Dourson's nomination two days hence, on Wednesday. So I need Dr. Dourson and EPA's response, today, Monday, please. Many thanks for your time, Daniel Forbes Cascadia Times Sierra Club v. EPA 18cv3472 NDCA Tier 13 ED 002061 00024005-00003